Searchable abstracts of presentations at key conferences in endocrinology

ea0020p87 | Thyroid | ECE2009

Long-term exogenous subclinical hyperthyroidism is not associated with decrased bone mineral density in men with differentiated thyroid carcinoma

Colome Eulalia , Reverter Jordi L , Holgado Susana , Puig Rocio , Alonso Nuria , Sanmarti Anna

Objectives: To determine the effect on bone mineral density (BMD) of the sub clinical hyperthyroidism (SH) due to TSH-suppressive treatment with levothyroxine after thyroidectomy in men with differentiated thyroid carcinoma (DTC).Materials and methods: Cross-sectional and retrospective study in 32 men (56±14 years) treated with levothyroxine for a minimum of 5 years, with TSH concentrations <0.05 mUI/ml and normal T3 levels in all determinations...

ea0026p392 | Thyroid (non cancer) | ECE2011

Increased Th1 response and regulatory CD4+CD25+CD127low/−FoxP3+ T cells in patients with chronic hepatitis C virus infection developing interferon-induced thyroiditis

Soldevila B , Alonso N , Martinez-Arconada M J , Julian T , Planas R , Pujol-Borrell R , Martinez-Caceres E M , Sanmarti A

Introduction: Interferon-α (IFN-α) exerts different immune effects and is used in current therapy for chronic hepatitis C virus (HCV) infection. One of the side-effects of IFN-α therapy is interferon-induced thyroiditis (IIT). The role of lymphocyte subpopulations in IIT remains to be defined.Objective: This study was conducted to assess different peripheral blood lymphocyte subpopulations, mainly regulatory CD4+CD25+...

ea0016p140 | Clinical cases | ECE2008

Prospective study of latent pernicious anemia markers in patients with type 1 diabetes mellitus

Alonso Nuria , Granada MaLuisa , Soldevila Berta , Salinas Isabel , Aguilera Eva , Junca Jordi , Puig Rocio , Pla Raquel , Martinez-Caceres Eva , Sanmarti Anna

Introduction: Patients with type 1 diabetes mellitus (DM1) present a high prevalence of autoimmune associated diseases. Recently, we described a prevalence of latent pernicious anemia (LPA) of 12.4% in DM1.Objectives: A 5-year follow-up study of a cohort of DM1 patients in order to evaluate the evolution of biochemical markers of LPA, defined as a serum pepsinogen I (PI) concentration below normal limits.Material and methods: One h...